Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.40 Analyst target: $300.00 Upside: 21323.98%
BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols that primarily involve adult stem cells. The company is headquartered in Melville, New York.
See the full interactive analysis & chart →Informational only — not investment advice.